tiprankstipranks
Trending News
More News >

Robinhood - New Portfolio

Orville

Robinhood
Individual Investor
Ranked #668,374 out of 827,344 TipRanks' Investors
Success Rate
34%
11 out of 32
profitable transactions
Average Return
-29.07%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 18.23%
6-Month Return▲ 20.64%
12-Month Return▼ 21.68%
YTD Return▼ 20.13%
Total Return▼ 81.94%

Best Trade

Opened at
Closed at-
Gain▲ 344.84%

Bio

Performance

22.06%0-22.06%
▲ 0.80%
▼ 0.87%
▼ 2.35%
Apr 2025
▲ 11.63%
▲ 6.28%
▼ 6.94%
May 2025
▲ 9.25%
▲ 5.14%
▲ 8.92%
Jun 2025
▲ 7.60%
▲ 2.30%
▼ 6.81%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 9.59%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 22.06%
Sep 2025
▲ 10.96%
▲ 2.38%
▼ 3.40%
Oct 2025
▼ 4.30%
▼ 1.63%
▼ 12.33%
Nov 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 0.80%▼ 0.87%▼ 2.35%
▲ 11.63%▲ 6.28%▼ 6.94%
▲ 9.25%▲ 5.14%▲ 8.92%
▲ 7.60%▲ 2.30%▼ 6.81%
▲ 2.76%▲ 2.05%▲ 9.59%
▲ 12.88%▲ 3.56%▲ 22.06%
▲ 10.96%▲ 2.38%▼ 3.40%
▼ 4.30%▼ 1.63%▼ 12.33%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Unity Biotechnology
▼ 98.38%
3
Close
Oct 01, 2025
Viracta Therapeutics
▼ 98.88%
2
Close
Jul 16, 2025
D-Wave Quantum
0%
▲ 92.06%
1
Open
May 21, 2025
Roundhill N-100 0DTE Covered Call Strategy ETF
0%
▲ 17.69%
1
Open
Oct 28, 2024
Werewolf Therapeutics
0%
▼ 61.15%
1
Open
Oct 28, 2024
Bright Minds Biosciences
0%
▲ 23.40%
1
Open
Oct 28, 2024
ARK 21Shares Bitcoin ETF Ben of Int
0%
▲ 71.03%
1
Open
Feb 28, 2024
Ocugen
0%
▲ 44.53%
1
Open
Feb 28, 2024
Vor Biopharma
0%
▼ 56.71%
1
Open
Feb 28, 2024
EyePoint Pharmaceuticals
81.92%
▲ 213.86%
2
Buy
May 18, 2023
Tenaya Therapeutics
5.46%
▼ 81.63%
2
Buy
May 18, 2023
IN8bio
0.19%
▼ 98.21%
2
Buy
May 18, 2023
Lantheus
12.44%
▼ 46.81%
1
Open
May 18, 2023
Antero Resources
▲ 19.22%
2
Close
May 16, 2023
SoFi
▼ 72.07%
2
Close
May 16, 2023
Camber Energy
▼ 99.30%
2
Close
May 16, 2023
Amyris
▼ 95.68%
2
Close
May 16, 2023
Lucid Group
▼ 71.56%
2
Close
May 16, 2023
Nio
▼ 77.43%
2
Close
May 16, 2023
Amazon
▲ 19.52%
2
Close
May 16, 2023